Table 3.
Hazard ratios for events per one unit increase in uFABP3/uCr.
| Unadjusted | P | Adjusted | P | |
|---|---|---|---|---|
| HR (95% CI) | HR (95% CI)‡ | |||
| MALE | 1.24 (1.10–1.40) | 0.001 | 1.28 (1.16–1.41) | 0.001 |
| Vascular intervention | 1.15 (1.02–1.28) | 0.031 | 1.13 (1.02–1.26) | 0.034 |
| Major amputation | 1.19 (0.92–1.55) | 0.19 | 1.19 (0.81–1.76) | 0.32 |
| Worsening PAD (drop in ABI ≥ 0.15) | 1.15 (1.04–1.27) | 0.009 | 1.16 (1.02–1.27) | 0.021 |
MALE, major adverse limb event: composite of vascular intervention and major amputation; PAD, peripheral artery disease; ABI, ankle brachial index.
Adjusted for age, sex, hypertension, dyslipidemia, diabetes, smoking, coronary artery disease, congestive heart failure, medications (statins, ACE-I/ARB, beta blocker, diuretic, ASA, antiplatelets other than ASA, and low-dose rivaroxaban), and serum creatinine. Bold values represent statistically significant values (p < 0.05).